These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22806936)
1. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559 [TBL] [Abstract][Full Text] [Related]
3. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening. Cuzick J; Adcock R; Carozzi F; Gillio-Tos A; De Marco L; Del Mistro A; Frayle H; Girlando S; Sani C; Confortini M; Zorzi M; Giorgi-Rossi P; Rizzolo R; Ronco G; Int J Cancer; 2020 Oct; 147(7):1864-1873. PubMed ID: 32170961 [TBL] [Abstract][Full Text] [Related]
4. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities. Zhao C; Zhao S; Heider A; Austin RM Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132 [TBL] [Abstract][Full Text] [Related]
5. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology. Zhang H; Varma KR; Han M; Matsko J; Zhao C Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678 [TBL] [Abstract][Full Text] [Related]
6. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand. Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209 [TBL] [Abstract][Full Text] [Related]
7. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain. Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073 [TBL] [Abstract][Full Text] [Related]
8. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy. Dijkstra MG; van Niekerk D; Rijkaart DC; van Kemenade FJ; Heideman DA; Snijders PJ; Meijer CJ; Berkhof J Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):55-63. PubMed ID: 23733907 [TBL] [Abstract][Full Text] [Related]
9. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Verdoodt F; Szarewski A; Halfon P; Cuschieri K; Arbyn M Cancer Cytopathol; 2013 Dec; 121(12):675-87. PubMed ID: 23881840 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy. Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396 [TBL] [Abstract][Full Text] [Related]
11. Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis. Arbyn M; Xu L; Verdoodt F; Cuzick J; Szarewski A; Belinson JL; Wentzensen N; Gage JC; Khan MJ Ann Intern Med; 2017 Jan; 166(2):118-127. PubMed ID: 27842420 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology. Peeters E; Wentzensen N; Bergeron C; Arbyn M Cancer Cytopathol; 2019 Mar; 127(3):169-180. PubMed ID: 30811902 [TBL] [Abstract][Full Text] [Related]
13. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969 [TBL] [Abstract][Full Text] [Related]
14. Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland. Jakobsson M; Tarkkanen J; Auvinen E; Häkkinen R; Laurila P; Tapper AM Int J STD AIDS; 2012 Jul; 23(7):485-9. PubMed ID: 22844002 [TBL] [Abstract][Full Text] [Related]
15. Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management. Castle PE; Aslam S; Behrens C Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1595-1599. PubMed ID: 27587789 [TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions. Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278 [TBL] [Abstract][Full Text] [Related]
17. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion? van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286 [TBL] [Abstract][Full Text] [Related]
18. [Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology]. Jin Y; Pan LY; Wang YF; Cheng XM; Lang JH Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1173-6. PubMed ID: 18844110 [TBL] [Abstract][Full Text] [Related]
19. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more. Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519 [TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]